フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
GSK PLC 26 March 2025 Transaction in own shares GSK plc (the "Company") announces today acting through its corporate stockbroker, Citigroup...
GSK on Tuesday said its urinary tract infection treatment gepotidacin, under the brand name Blujepa, has been approve ...
GSK PLC 25 March 2025 Issued: 25 March 2025, London UK Blujepa (gepotidacin) approved by US FDA for treatment of uncomplicated urinary tract...
GSK PLC 25 March 2025 Transaction in own shares GSK plc (the "Company") announces today acting through its corporate stockbroker, Citigroup...
GSK PLC 24 March 2025 GSK plc (the 'Company') Publication of Notice of Annual General Meeting 2025 The Company has today published on its...
GSK PLC on Monday said it has had an application to expand the use of mepolizumab for the treatment of chronic obstru ...
GSK PLC 24 March 2025 Issued: 24 March 2025, London UK GSK's application to expand use of Nucala (mepolizumab) for the treatment of COPD...
GSK PLC 24 March 2025 Transaction in own shares GSK plc (the "Company") announces today acting through its corporate stockbroker, Citigroup...
GSK PLC 21 March 2025 GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name...
GSK PLC 21 March 2025 Transaction in own shares GSK plc (the "Company") announces today acting through its corporate stockbroker, Citigroup...
GSK PLC 20 March 2025 Transaction in own shares GSK plc (the "Company") announces today acting through its corporate stockbroker, Citigroup...
GSK PLC 19 March 2025 Transaction in own shares GSK plc (the "Company") announces today acting through its corporate stockbroker, Citigroup...
GSK PLC 18 March 2025 Transaction in own shares GSK plc (the "Company") announces today acting through its corporate stockbroker, Citigroup...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
サインアップして広告なしのエクスペリエンスを体験してください
今すぐ試してください
広告を残す